Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) for Thromboembolic Prevention, Are They Safe in Congenital Heart Disease? Results of a Worldwide Study
International Journal of Cardiology - Ireland
doi 10.1016/j.ijcard.2019.06.014
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Elsevier BV